Reuters logo
BRIEF-Vistin Pharma Q1 operating profit down at NOK 5.8 million
April 26, 2017 / 5:10 AM / 5 months ago

BRIEF-Vistin Pharma Q1 operating profit down at NOK 5.8 million

April 26 (Reuters) - VISTIN PHARMA ASA

* TOTAL REVENUES OF NOK 97.3 MILLION IN Q1 OF 2017, COMPARED TO NOK 103.2 MILLION IN Q1 OF 2016

* TO INVEST IN A NEW PRODUCTION LINE AT ITS METFORMIN PLANT IN KRAGERØ, NORWAY, WILL EFFECTIVELY DOUBLE VISTIN PHARMA‘S PRODUCTION CAPACITY UPON COMPLETION IN 2019

* CAPACITY EXPANSION WILL REQUIRE AN INVESTMENT OF APPROXIMATELY NOK 120 MILLION, WHICH WILL BE FINANCED THROUGH EXISTING CASH RESERVES, CASH GENERATION AND DEBT

* Q1 OPERATING PROFIT NOK 5.8 MILLION VERSUS NOK 10.1 MILLION YEAR AGO Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below